全文获取类型
收费全文 | 5532篇 |
免费 | 476篇 |
国内免费 | 4篇 |
出版年
2023年 | 26篇 |
2022年 | 74篇 |
2021年 | 130篇 |
2020年 | 58篇 |
2019年 | 71篇 |
2018年 | 92篇 |
2017年 | 77篇 |
2016年 | 140篇 |
2015年 | 216篇 |
2014年 | 228篇 |
2013年 | 286篇 |
2012年 | 403篇 |
2011年 | 320篇 |
2010年 | 220篇 |
2009年 | 181篇 |
2008年 | 293篇 |
2007年 | 293篇 |
2006年 | 254篇 |
2005年 | 227篇 |
2004年 | 226篇 |
2003年 | 183篇 |
2002年 | 169篇 |
2001年 | 184篇 |
2000年 | 162篇 |
1999年 | 129篇 |
1998年 | 52篇 |
1997年 | 44篇 |
1996年 | 28篇 |
1995年 | 38篇 |
1994年 | 36篇 |
1993年 | 35篇 |
1992年 | 92篇 |
1991年 | 77篇 |
1990年 | 80篇 |
1989年 | 84篇 |
1988年 | 61篇 |
1987年 | 62篇 |
1986年 | 68篇 |
1985年 | 68篇 |
1984年 | 54篇 |
1983年 | 49篇 |
1982年 | 40篇 |
1981年 | 28篇 |
1980年 | 31篇 |
1979年 | 42篇 |
1978年 | 31篇 |
1976年 | 27篇 |
1975年 | 27篇 |
1974年 | 34篇 |
1973年 | 36篇 |
排序方式: 共有6012条查询结果,搜索用时 375 毫秒
861.
Jian-kang Jiang Xiuli Huang Khalida Shamim Paresma R. Patel Arthur Lee Amy Q. Wang Kimloan Nguyen Gregory Tawa Gregory D. Cuny Paul B. Yu Wei Zheng Xin Xu Philip Sanderson Wenwei Huang 《Bioorganic & medicinal chemistry letters》2018,28(20):3356-3362
The pyrazolo[1,5-a]pyrimidine LDN-193189 is a potent inhibitor of activin receptor-like kinase 2 (ALK2) but is nonselective for highly homologous ALK3 and shows only modest kinome selectivity. Herein, we describe the discovery of a novel series of potent and selective ALK2 inhibitors by replacing the quinolinyl with a 4-(sulfamoyl)naphthyl, yielding ALK2 inhibitors that exhibit not only excellent discrimination versus ALK3 but also high kinome selectivity. In addition, the optimized compound 23 demonstrates good ADME and in vivo pharmacokinetic properties. 相似文献
862.
Sobhana Babu Boga Abdul-Basit Alhassan Alan B. Cooper Ronald Doll Neng-Yang Shih Gerald Shipps Yongqi Deng Hugh Zhu Yang Nan Robert Sun Liang Zhu Jagdish Desai Mehul Patel Kiran Muppalla Xiaolei Gao James Wang Xin Yao Joseph Kelly Robert Bishop 《Bioorganic & medicinal chemistry letters》2018,28(11):2029-2034
Compound 5 (SCH772984) was identified as a potent inhibitor of ERK1/2 with excellent selectivity against a panel of kinases (0/231 kinases tested @ 100?nM) and good cell proliferation activity, but suffered from poor PK (rat AUC PK @10?mpk?=?0?μM?h; F%?=?0) which precluded further development. In an effort to identify novel ERK inhibitors with improved PK properties with respect to 5, a systematic exploration of sterics and composition at the 3-position of the pyrrolidine led to the discovery of a novel 3(S)-thiomethyl pyrrolidine analog 28 with vastly improved PK (rat AUC PK @10?mpk?=?26?μM?h; F%?=?70). 相似文献
863.
864.
Barzkar Noora Homaei Ahmad Hemmati Roohullah Patel Seema 《Extremophiles : life under extreme conditions》2018,22(3):335-346
Extremophiles - Thermostable proteases are important in biotechnological and industrial sectors, due to their stability against denaturing agents and chemicals. The feature that gives them such... 相似文献
865.
Winnie Ip Juliana M.F. Silva Hubert Gaspar Arindam Mitra Shreenal Patel Kanchan Rao Robert Chiesa Persis Amrolia Kimberly Gilmour Gul Ahsan Mary Slatter Andrew R. Gennery Robert F. Wynn Paul Veys Waseem Qasim 《Cytotherapy》2018,20(6):830-838
Background
Adenovirus (ADV) reactivation can cause significant morbidity and mortality in children after allogeneic stem cell transplantation. Antiviral drugs can control viremia, but viral clearance requires recovery of cell-mediated immunity.Method
This study was an open-label phase 1/2 study to investigate the feasibility of generating donor-derived ADV-specific T cells (Cytovir ADV, Cell Medica) and to assess the safety of pre-emptive administration of ADV-specific T cells in high-risk pediatric patients after allogeneic hematopoietic stem cell transplantation (HSCT) to treat adenoviremia. Primary safety endpoints included graft-versus-host disease (GvHD), and secondary endpoints determined antiviral responses and use of antiviral drugs.Results
Between January 2013 and May 2016, 92 donors were enrolled for the production of ADV T cells at three centers in the United Kingdom (UK), and 83 products were generated from 72 mobilized peripheral blood harvests and 20 steady-state whole blood donations. Eight children received Cytovir ADV T cells after standard therapy and all resolved ADV viremia between 15 and 127 days later. ADV-specific T cells were detectable using enzyme-linked immunospot assay (ELISpot) in the peripheral blood of all patients analyzed. Serious adverse events included Grade II GvHD, Astrovirus encephalitis and pancreatitis.Conclusion
The study demonstrates the safety and feasibility of pre-emptively manufacturing peptide pulsed ADV-specific cells for high-risk pediatric patients after transplantation and provides early evidence of clinical efficacy. 相似文献866.
Antioxidant,anti‐inflammatory,and enzyme inhibitory activity of natural plant flavonoids and their synthesized derivatives
下载免费PDF全文
![点击此处可从《Journal of biochemical and molecular toxicology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Shivraj Hariram Nile Young Soo Keum Arti Shivraj Nile Shivkumar S. Jalde Rahul V. Patel 《Journal of biochemical and molecular toxicology》2018,32(1)
The synthesized flavonoid derivatives were examined for their antioxidant, anti‐inflammatory, xanthine oxidase (XO), urease inhibitory activity, and cytotoxicity. Except few, all the flavonoids under this study showed significant antioxidant activity (45.6%–85.5%, 32.6%–70.6%, and 24.9%–65.5% inhibition by DPPH, ferric reducing/antioxidant power, and oxygen radical absorption capacity assays) with promising TNF‐α inhibitory activity (42%–73% at 10 μM) and IL‐6 inhibitory activity (54%–81% at 10 μM) compared with that of control dexamethasone. The flavonoids luteolin, apigenin, diosmetin, chrysin, O3?, O7‐dihexyl diosmetin, O4?, O7‐dihexyl apigenin, and O7‐hexyl chrysin, showed an inhibition with IC50 values (4.5‐8.1 μg/mL), more than allopurinol (8.5 μg/mL) at 5 μM against XO and showing more than 50% inhibition at a final concentration (5 mM) with an IC50 value of ranging from 4.8 to 7.2 (μg/mL) in comparison with the positive control thiourea (5.8 μg/mL) for urease inhibition. Thus, the flavonoid derivatives may be considered as potential antioxidant and antigout agents. 相似文献
867.
868.
Amr Omer Devang Patel Xian Jin Lian Jason Sadek Sergio Di Marco Arnim Pause Myriam Gorospe Imed Eddine Gallouzi 《EMBO reports》2018,19(5)
Cellular senescence is a physiological response by which an organism halts the proliferation of potentially harmful and damaged cells. However, the accumulation of senescent cells over time can become deleterious leading to diseases and physiological decline. Our data reveal a novel interplay between senescence and the stress response that affects both the progression of senescence and the behavior of senescent cells. We show that constitutive exposure to stress induces the formation of stress granules (SGs) in proliferative and presenescent cells, but not in fully senescent cells. Stress granule assembly alone is sufficient to decrease the number of senescent cells without affecting the expression of bona fide senescence markers. SG‐mediated inhibition of senescence is associated with the recruitment of the plasminogen activator inhibitor‐1 (PAI‐1), a known promoter of senescence, to these entities. PAI‐1 localization to SGs increases the translocation of cyclin D1 to the nucleus, promotes RB phosphorylation, and maintains a proliferative, non‐senescent state. Together, our data indicate that SGs may be targets of intervention to modulate senescence in order to impair or prevent its deleterious effects. 相似文献
869.
Jonathan D. Finn Amy Rhoden Smith Mihir C. Patel Lucinda Shaw Madeleine R. Youniss Jane van Heteren Tanner Dirstine Corey Ciullo Reynald Lescarbeau Jessica Seitzer Ruchi R. Shah Aalok Shah Dandan Ling Jacqueline Growe Melissa Pink Ellen Rohde Kristy M. Wood William E. Salomon David V. Morrissey 《Cell reports》2018,22(9):2227-2235
870.
Helen Louise May-Simera Qin Wan Balendu Shekhar Jha Juliet Hartford Vladimir Khristov Roba Dejene Justin Chang Sarita Patnaik Quanlong Lu Poulomi Banerjee Jason Silver Christine Insinna-Kettenhofen Dishita Patel Mostafa Lotfi May Malicdan Nathan Hotaling Arvydas Maminishkis Rupa Sridharan Kapil Bharti 《Cell reports》2018,22(1):189-205